Insmed, Inc. (INSM)
114.40
+5.64
(+5.19%)
USD |
NASDAQ |
Nov 06, 16:00
114.48
+0.08
(+0.07%)
After-Hours: 20:00
Insmed Total Long Term Debt (Quarterly) : 741.61M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 741.61M |
| June 30, 2026 | 741.01M |
| March 31, 2026 | 743.43M |
| December 31, 2025 | 746.52M |
| September 30, 2025 | 740.94M |
| June 30, 2025 | 739.82M |
| March 31, 2025 | 1.306B |
| December 31, 2024 | 1.305B |
| September 30, 2024 | 1.156B |
| June 30, 2024 | 1.373B |
| March 31, 2024 | 1.366B |
| December 31, 2023 | 1.354B |
| September 30, 2023 | 1.347B |
| June 30, 2023 | 1.339B |
| March 31, 2023 | 1.331B |
| December 31, 2022 | 1.321B |
| September 30, 2022 | 824.32M |
| June 30, 2022 | 825.52M |
| March 31, 2022 | 826.66M |
| December 31, 2021 | 602.74M |
| September 30, 2021 | 595.25M |
| June 30, 2021 | 587.43M |
| March 31, 2021 | 401.18M |
| December 31, 2020 | 393.37M |
| September 30, 2020 | 389.91M |
| Date | Value |
|---|---|
| June 30, 2020 | 391.26M |
| March 31, 2020 | 388.60M |
| December 31, 2019 | 386.00M |
| September 30, 2019 | 362.42M |
| June 30, 2019 | 359.66M |
| March 31, 2019 | 357.02M |
| December 31, 2018 | 316.56M |
| September 30, 2018 | 311.86M |
| June 30, 2018 | 307.16M |
| March 31, 2018 | 302.71M |
| December 31, 2017 | 55.57M |
| September 30, 2017 | 55.39M |
| June 30, 2017 | 55.19M |
| March 31, 2017 | 54.99M |
| December 31, 2016 | 54.79M |
| September 30, 2016 | 34.68M |
| June 30, 2016 | 24.82M |
| March 31, 2016 | 24.79M |
| December 31, 2015 | 25.14M |
| September 30, 2015 | 25.26M |
| June 30, 2015 | 25.12M |
| March 31, 2015 | 24.99M |
| December 31, 2014 | 24.86M |
| September 30, 2014 | 19.91M |
| June 30, 2014 | 19.81M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Gilead Sciences, Inc. | 26.23B |
| Incyte Corp. | 31.76M |
| Vertex Pharmaceuticals, Inc. | 5.479B |
| Regeneron Pharmaceuticals, Inc. | 2.707B |